Compounds for use in the treatment of conditions associated with NADPH oxidase
申请人:Glucox Biotech AB
公开号:US10195167B2
公开(公告)日:2019-02-05
A compound of formula (I) or a pharmaceutically acceptable salt thereof, for use in the treatment of a condition or disorder associated with nicotinamide adenine dinucleotide phosphate oxidase.
COMPOUNDS FOR USE IN THE TREATMENT OF CONDITIONS ASSOCIATED WITH NADPH OXIDASE
申请人:Glucox Biotech AB
公开号:EP3233072A1
公开(公告)日:2017-10-25
[EN] COMPOUNDS FOR USE IN THE TREATMENT OF CONDITIONS ASSOCIATED WITH NADPH OXIDASE<br/>[FR] COMPOSÉS POUR UNE UTILISATION DANS LE TRAITEMENT DE CONDITIONS ASSOCIÉES À LA NADPH OXYDASE
申请人:GLUCOX BIOTECH AB
公开号:WO2016096720A1
公开(公告)日:2016-06-23
A compound of formula (I) or a pharmaceutically acceptable salt thereof, for use in the treatment of a condition or disorder associated with nicotinamide adenine dinucleotide phosphate oxidase.